Authors: STERKY F REGAN S KARLSSON J HERTZBERG M ROHDE A HOLMBERG A AMINI B BHALERAO R LARSSON M VILLARROEL R VANMONTAGU M SANDBERG G OLSSON O TEERI TT BOERJAN W GUSTAFSSON P UHLEN M SUNDBERG B LUNDEBERG J

Citation: F. Sterky et al., GENE DISCOVERY IN THE WOOD-FORMING TISSUES OF POPLAR - ANALYSIS OF 5,692 EXPRESSED SEQUENCE TAGS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(22), 1998, pp. 13330-13335

Authors: HERTZBERG M FELDMAN M BECKHAM J MOORE S DAVIDSON J

Citation: M. Hertzberg et al., OPEN TRIAL OF NEFAZODONE TREATMENT FOR POSTTRAUMATIC-STRESS-DISORDER, Psychopharmacology bulletin, 33(3), 1997, pp. 529-529

Authors: DAVIDSON JRT BOOK SW COLKET JT TUPLER LA ROTH S DAVID D HERTZBERG M MELLMAN T BECKHAM JC SMITH RD DAVISON RM KATZ R FELDMAN ME

Citation: Jrt. Davidson et al., ASSESSMENT OF A NEW SELF-RATING SCALE FOR POSTTRAUMATIC-STRESS-DISORDER, Psychological medicine, 27(1), 1997, pp. 153-160

Authors: ARTHUR CK ENNO A FIRKIN F MA D ILAND H CONCANNON A YOUNG G SHAW P GALLO J HERTZBERG M

Citation: Ck. Arthur et al., A DOSE-ESCALATION STUDY OF HIGH-DOSE INTERFERON-ALPHA 2A (HDIFN) UP TO 18 MILLION UNITS DAILY IN PATIENTS WITH POOR-PROGNOSIS CHRONIC MYELOID-LEUKEMIA (CML) OR GOOD PROGNOSIS PATIENTS WHO HAVE FAILED TREATMENTWITH IFN PLUS CYTOSINE-ARABINOSIDE (ARA-C), Blood, 88(10), 1996, pp. 2291-2291

Authors: HERTZBERG M

Citation: M. Hertzberg, BIOCHEMISTRY OF FACTOR-X, Blood reviews, 8(1), 1994, pp. 56-62